LOADING
Comparing Eli Lilly and Company (LLY) and Mastercard Inc (MA) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | MA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $808.2B | $456.3B |
| P/E Ratio | 40.1 | 30.9 |
| Forward P/E | 26.7 | 26.4 |
| PEG Ratio | 1.33 | 1.65 |
| EPS | $22.49 | $16.52 |
| Revenue Growth (YoY) | 42.6% | 17.6% |
| Profit Margin | 31.7% | 45.7% |
| Return on Equity | 101.2% | 209.9% |
| Dividend Yield | 0.65% | 0.61% |
| Beta | 0.50 | 0.83 |
| 52-Week High | $1,132.06 | $599.05 |
| 52-Week Low | $620.46 | $479.68 |
| Volume | -- | -- |
Eli Lilly and Company is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Eli Lilly and Company offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.